Possible mechanisms of action of adrenal transplants in Parkinson's disease.
Drucker-Colín
R
R
Departamento de Neurociencias, Universidad Nacional Autonoma de Mexico, D.F.
García-Hernández
F
F
Mendoza-Ramírez
J L
JL
Pacheco-Cano
M T
MT
Komisaruk
B R
BR
D000313:Adrenal Medulla / Q000502:physiology / Q000637:transplantation*; D000375:Aging / Q000502:physiology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D016380:Brain Tissue Transplantation / Q000502:physiology; D003994:Bucladesine / Q000494:pharmacology; D002421:Caudate Nucleus / Q000503:physiopathology; D002552:Cerebral Ventricles; D004292:Dominance, Cerebral; D004298:Dopamine / Q000378:metabolism; D016332:Fetal Tissue Transplantation / Q000502:physiology; D006892:Hydroxydopamines; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D016627:Oxidopamine; D010146:Pain / Q000503:physiopathology*; D010300:Parkinson Disease / Q000503:physiopathology / Q000601:surgery*; D051381:Rats; D011919:Rats, Inbred Strains; D012684:Sensory Thresholds / Q000187:drug effects; D013378:Substantia Nigra / Q000503:physiopathology / Q000637:transplantation; D016042:Transplantation, Heterotopic / Q000502:physiology*
D006892:Hydroxydopamines; D003994:Bucladesine; D016627:Oxidopamine; D001058:Apomorphine; D004298:Dopamine